QNTMQuantum BioPharma Ltd.

QNTM Stock Price, Valuation & Chart | Quantum BioPharma Ltd.

$3.080+0.04 (+1.32%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic QNTM intrinsic value QNTM calculated fair value vs price

Overview Financials Dividends Ratios

QNTM Historical price chart

QNTM Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization19.71M

PE Ratio-0.62

EPS-4.97

Trading Volume41.34K

Today's High/Low3.15/3.0

Dividend Yield0.00

52 Week High/Low21.0/2.07

Shares Outstanding6.40M

QNTM Financial Statement

QNTM Analyst ratings

QNTM Analysis & performance metrics

QNTM Company profile

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative,…

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its…

QNTM Management team

Name

Position

Donal Carroll CPACFO

Chief Financial Officer

Lakshmi P. Kotra BPHARM, Ph.D.CEO

Chief Executive Officer of Lucid & Director

Zeeshan SaeedCEO

Founder, Chief Executive Officer, President & Executive Co-Chairman

Nathan Coyle CPA

Controller

Ashwini JoshiCTO

Director of Pharmaceutical Development

Jason D. Sawyer

Head of Finance & Mergers and Acquisitions

Andrzej Chruscinski M.D., Ph.D.

Vice President of Clinical & Scientific Affairs

Maryann Adesso

Corporate Secretary

Name

Position

Donal Carroll CPACFO

Chief Financial Officer

Lakshmi P. Kotra BPHARM, Ph.D.CEO

Chief Executive Officer of Lucid & Director

Zeeshan SaeedCEO

Founder, Chief Executive Officer, President & Executive Co-Chairman

Nathan Coyle CPA

Controller

Ashwini JoshiCTO

Director of Pharmaceutical Development

Jason D. Sawyer

Head of Finance & Mergers and Acquisitions

Andrzej Chruscinski M.D., Ph.D.

Vice President of Clinical & Scientific Affairs

Maryann Adesso

Corporate Secretary

Management Team

Donal Carroll CPACFO

Chief Financial Officer

Lakshmi P. Kotra BPHARM, Ph.D.CEO

Chief Executive Officer of Lucid & Director

Zeeshan SaeedCEO

Founder, Chief Executive Officer, President & Executive Co-Chairman

Nathan Coyle CPA

Controller

Ashwini JoshiCTO

Director of Pharmaceutical Development

Jason D. Sawyer

Head of Finance & Mergers and Acquisitions

Andrzej Chruscinski M.D., Ph.D.

Vice President of Clinical & Scientific Affairs

Maryann Adesso

Corporate Secretary

Management

Donal Carroll CPACFO

Chief Financial Officer

Lakshmi P. Kotra BPHARM, Ph.D.CEO

Chief Executive Officer of Lucid & Director

Zeeshan SaeedCEO

Founder, Chief Executive Officer, President & Executive Co-Chairman

Nathan Coyle CPA

Controller

Ashwini JoshiCTO

Director of Pharmaceutical Development

Jason D. Sawyer

Head of Finance & Mergers and Acquisitions

Andrzej Chruscinski M.D., Ph.D.

Vice President of Clinical & Scientific Affairs

Maryann Adesso

Corporate Secretary

Total 8 executives

QNTM Frequently asked questions

What is Quantum BioPharma Ltd. (QNTM) Stock Price?

Current stock price of Quantum BioPharma Ltd. (QNTM) stock is $3.080. The stock price is +1.32% higher in the session. The intraday range can be seen from this page. Volume of Quantum BioPharma Ltd. (QNTM) stock is 41.34K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Quantum BioPharma Ltd. (QNTM) stock price going up or down today?

The stock price of Quantum BioPharma Ltd. (QNTM) can change with earnings, company news, and overall market sentiment. Quantum BioPharma Ltd. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Quantum BioPharma Ltd. stock expensive at its current price?

Whether Quantum BioPharma Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for QNTM on this page is -0.62. EPS on this page is -4.97. Compare those figures with peers and growth expectations before deciding if the current Quantum BioPharma Ltd. price is justified.

How has the stock price of Quantum BioPharma Ltd. (QNTM) performed historically?

Historical performance for Quantum BioPharma Ltd. (QNTM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how QNTM reacted to past earnings and market events.

Should I buy Quantum BioPharma Ltd. (QNTM) stock, at this price?

Buying Quantum BioPharma Ltd. (QNTM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.